Product Images Fesoterodine Fumarate

NDC 62559-376-30 is a prescription drug called Fesoterodine Fumarate Extended-release Tablets. Each film-coated tablet contains 8 mg of fesoterodine fumarate. This medication is dispensed in a tight, light-resistant container, and it should be protected from moisture. The tablets should be stored at room temperature, between 20°C to 25°C. The prescribing information should be consulted for dosage instructions. The medication is manufactured by Suzhou Amerigen Pharmaceutical Co. Ltd. in China and distributed by ANI Pharmaceuticals in Baudette, MN. Swallow the tablet whole and do not crush, divide or chew it. Keep this medication and all other medicines out of children's reach.*

This appears to be a medical document that mentions a medication called Fesoterodine Fumarate in extended-release tablets with a dosage of 8 mg. The text also references a change in the number of micturitions per day (presumably related to urinary frequency), but it lacks sufficient context to interpret the information fully.*

This appears to be a table displaying the mean change in the number of micturitions (urinations) per 24-hour period for subjects taking fesoterodine fumarate tablets compared to those taking a placebo. There are three groups: one taking 4mg doses, one taking 8mg doses, and a control group taking a placebo. The number of subjects in each group is also provided.*

The text provides data on the mean change from baseline in urge incontinence episodes per 24 hours for a study comparing fesoterodine fumarate extended-release tablets to placebo. The mean change from baseline was 20 in the placebo group (n=205) and the text does not provide the corresponding data for the treatment group.*